XML 102 R85.htm IDEA: XBRL DOCUMENT v3.10.0.1
Long-term Equity-based Compensation - Activity Related to Nonvested Restricted Stock (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total fair value of DSUs that vested during the years $ 1.0 $ 0.9 $ 0.5
Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vested in Period, Total Fair Value 8.7 3.2 1.3
Income tax benefit from share-based compensation $ 1.8 $ 1.1 $ 0.5
Performance Based Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Reduction in share authorization if maximum performance level is met or exceeded (shares) 981,900    
Time Vested Restricted Stock Units [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Nonvested Balance at Beginning of Year, Restricted Shares 130,247    
Nonvested at Beginning of Year, Weighted Average Grant Date Fair Value (per share) $ 40.34    
Grants in Period 249,422    
Grants in Period, Weighted Average Grant Date Fair Value (per share) $ 73.94    
Vested in Period (51,647)    
Vested in Period, Weighted Average Grant Date Fair Value (per share) $ 49.76    
Forfeited in Period (11,781)    
Forfeited in Period, Weighted Average Grant Date Fair Value (per share) $ 38.71    
Nonvested Balance at End of Year, Restricted Shares 316,241 130,247  
Nonvested at End of Year, Weighted Average Grant Date Fair Value (per share) $ 65.36 $ 40.34  
Performance Based Restricted Stock Units [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Nonvested Balance at Beginning of Year, Restricted Shares 225,983    
Nonvested at Beginning of Year, Weighted Average Grant Date Fair Value (per share) $ 36.90    
Grants in Period 191,292    
Grants in Period, Weighted Average Grant Date Fair Value (per share) $ 56.88    
Vested in Period   (77,244)  
Vested in Period, Weighted Average Grant Date Fair Value (per share)   $ 37.63  
Forfeited in Period (12,731)    
Forfeited in Period, Weighted Average Grant Date Fair Value (per share) $ 47.71    
Nonvested Balance at End of Year, Restricted Shares 327,300 225,983  
Nonvested at End of Year, Weighted Average Grant Date Fair Value (per share) $ 47.14 $ 36.90  
Performance Period, 2017 to 2019 [Member] | Performance Based Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Additional Shares To Be Granted If Maximum Performance Level Is Met or Exceeded 142,413    
Reduction in share authorization if maximum performance level is met or exceeded (shares) 427,239    
Performance Period, 2016 to 2018 [Member] | Performance Based Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Additional Shares To Be Granted If Maximum Performance Level Is Met or Exceeded 80,999    
Reduction in share authorization if maximum performance level is met or exceeded (shares) 242,997    
Performance Period, 2015 to 2017 [Member] | Performance Based Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Additional Shares To Be Granted If Maximum Performance Level Is Met or Exceeded 103,888    
Reduction in share authorization if maximum performance level is met or exceeded (shares) 311,664